Mutation status such as TP53, BRCA1 and BRCA2 [50,51] are also important factors, which may contribute to tumor progression and chemoresistance of an ovarian tumor tissue or cell line, especially in relation to their role in apoptosis. Here, TP53 is linked to ovarian neoplasm.